Generics 137

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Terbinafine manufacturers

137 products found

Filters

137 products found

terbinafine

Tablets 250mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Germany , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

terbinafine

Cream 150mg/15g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Germany , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam , Hungary
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

terbinafine

Tablets, film coated 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Lamisil®
Manufacturer #252

Manufacturer usually replies in 2 days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Greece
Manufacturer #17290
A pharmaceutical manufacturer based in the EU that is active in Europe, Africa, and Asia for 100+ years. Key production lines are pharmaceuticals, food supplements, OTC, and cosmetics. The main therapeutic areas include dermatology, respiratory system, and antibiotic.

Manufacturer usually replies in 4 days

terbinafine

Cream 1 %

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Lamisil®
Manufacturer #252

Manufacturer usually replies in 2 days

terbinafine

Cutaneous spray 10mg / g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17345
It was founded in the 1930s. The company is dedicated to contributing to the recovery of patients. It is important for the company to always be at the service of patients with modern products, so they consider research and development to be a priority, thus they constantly expanding product range helps people to recover. They mainly produce over-the-counter generic medicines at extremely low prices. They have both a manufacturing license for human medicines and a manufacturing license for veterinary products in addition to the production of the registered product.

Manufacturer usually replies in 8 days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

terbinafine

Tablets 250mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #673
A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, CIS, and Oceania for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include neurology, cardiology, and infectiology. The company's production lines are EU GMP-compliant. The company possesses branches in 10+ countries in Europe and CIS.

Manufacturer usually replies in 8 days

terbinafine

Cutaneous spray 10mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

terbinafine

Cream 1 % - 15 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Lamisil
Manufacturer #417
A pharmaceutical manufacturer based in the EU that has been active in 30+ countries selling its products in Europe, North America, Middle East, CIS, Africa, Oceania, and Asia for 40+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant. Main dosage forms include oral solutions, gels, oral suspensions, and topicals. The company prepares a CTD format dossier.

Manufacturer usually replies in 8 days

terbinafine

Tablets 250mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #12170
This company has been involved in the development, production, and regulatory support of generic pharmaceuticals for over 20+ years and has offices at various locations. They have more than 20+ generic medications registered across Europe. The items are sold on more than five continents.

Manufacturer usually replies in 8 days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

terbinafine

Cream 10 mg/g - 15 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years. Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders. The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture. Regularity team prepares EU CTD format document.

Manufacturer usually replies in 16 days

terbinafine

Cream 10 mg, 1 g - 30 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #31063

Manufacturer usually replies in nan days

terbinafine

Tablets 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #31063

Manufacturer usually replies in nan days

terbinafine

Oral spray 10 mg, 1 g - 30 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #31063

Manufacturer usually replies in nan days

terbinafine

Cream 1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

terbinafine

Cream 1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

terbinafine

Cutaneous spray 1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

Want to view all 137 products? Create your free account today!

Terbinafine is an antifungal medication pityriasis versicolor, fungal nail infections, tinea capitis, tinea corporis, tinea cruris, tinea pedis, and cutaneous candidiasis. Terbinafine manufacturers produce medications with it as the standalone ingredient, as well as use it in combination drug formulations along with ingredients such as mometasone and urea. Suppliers of terbinafine market it in the form of 125mg and 250mg oral tablets as well as 10mg/g topical creams. The developer and earliest manufacturer of terbinafine was Novartis, who first introduced it into the market under the trade name Lamisil in Europe in 1991, and the U.S. in 1996. Lamisil is currently available in over 70 countries worldwide, including but not limited to Australia, Brazil, Russia, South Africa, Thailand, and many more geographical markets. What is more, following the expiry of the manufacturer’s patent in 2007, other producers and suppliers launched their formulations of the drug into the market. Terbinafine is included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. And it is a widely prescribed drug, with over 1 million prescriptions being registered yearly in the U.S. alone. The global terbinafine market is fragmented, with multiple pharmaceutical companies, from small local manufacturers to large multinational industry players marketing both generic and trade name terbinafine formulations. Among the largest manufacturers and suppliers of terbinafine are well-known names such as Novartis, GlaxoSmithKline, Gedeon Richter, Sun Pharmaceuticals, Teva, Pfizer, and Mylan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified terbinafine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Costs per 28 (250mg) tablets of terbinafine range from 25 EUR to 30 EUR, whereas 15g (10mg/g) of terbinafine topical cream can cost anywhere from 4,00 EUR to 11,00 EUR.